- Home
- EPIX vs IMRX Comparison
EPIX vs IMRX Comparison
Compare EPIX & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPIX
- IMRX
- Stock Information
- Founded
- EPIX 2009
- IMRX 2008
- Country
- EPIX Canada
- IMRX United States
- Employees
- EPIX N/A
- IMRX N/A
- Industry
- EPIX Biotechnology: Pharmaceutical Preparations
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- EPIX Health Care
- IMRX Health Care
- Exchange
- EPIX Nasdaq
- IMRX Nasdaq
- Market Cap
- EPIX 76.8M
- IMRX 62.7M
- IPO Year
- EPIX N/A
- IMRX 2021
- Fundamental
- Price
- EPIX $1.59
- IMRX $1.65
- Analyst Decision
- EPIX Hold
- IMRX Buy
- Analyst Count
- EPIX 3
- IMRX 6
- Target Price
- EPIX $2.00
- IMRX $9.00
- AVG Volume (30 Days)
- EPIX 94.8K
- IMRX 198.5K
- Earning Date
- EPIX 05-13-2025
- IMRX 05-06-2025
- Dividend Yield
- EPIX N/A
- IMRX N/A
- EPS Growth
- EPIX N/A
- IMRX N/A
- EPS
- EPIX N/A
- IMRX N/A
- Revenue
- EPIX N/A
- IMRX N/A
- Revenue This Year
- EPIX N/A
- IMRX N/A
- Revenue Next Year
- EPIX N/A
- IMRX N/A
- P/E Ratio
- EPIX N/A
- IMRX N/A
- Revenue Growth
- EPIX N/A
- IMRX N/A
- 52 Week Low
- EPIX $1.40
- IMRX $1.00
- 52 Week High
- EPIX $9.60
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- EPIX 36.22
- IMRX 48.23
- Support Level
- EPIX $1.58
- IMRX $1.42
- Resistance Level
- EPIX $1.70
- IMRX $1.71
- Average True Range (ATR)
- EPIX 0.05
- IMRX 0.09
- MACD
- EPIX -0.00
- IMRX 0.03
- Stochastic Oscillator
- EPIX 15.38
- IMRX 80.65
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company is focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It is developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.